ArticlePharmaceutics2021

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation.

Itziar Gómez-Aguado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.